SCHEMBL2955709

SCHEMBL2955709

Cc1ccccc1-n1c(=O)ccc2c(N)c(C#N)sc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
KDM4E B2RXH2 5/20 0.40
KMT2A Q03164 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HSD17B10 Q99714 3/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
XBP1 P17861 1/20 0.40
HPGD P15428 2/20 0.37
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
S1PR1 P21453 1/20 0.37
RXFP1 Q9HBX9 2/20 0.36
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1265636 0.85 ALDH1A1 (0.37) ALDH1A1KDM4EKMT2ASMN1; SMN2HSD17B10
SCHEMBL2780092 0.82 ALDH1A1 (0.38) ALDH1A1KDM4EKMT2ASMN1; SMN2HSD17B10
SCHEMBL2960372 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EKMT2ASMN1; SMN2HSD17B10
SCHEMBL2952051 0.76 IDO1 (0.38) ALDH1A1KDM4EKMT2ASMN1; SMN2HSD17B10
SCHEMBL2959772 0.74 ALDH1A1 (0.38) ALDH1A1KDM4EKMT2ASMN1; SMN2MEN1
SCHEMBL2950115 0.74 LMNA (0.35) ALDH1A1KDM4EKMT2ASMN1; SMN2MEN1
SCHEMBL2949358 0.73 EP300 (0.37) ALDH1A1KDM4EKMT2ASMN1; SMN2HSD17B10
SCHEMBL2959253 0.69 KDM4E (0.38) ALDH1A1KDM4EKMT2ASMN1; SMN2HSD17B10
SCHEMBL2782820 0.66 ALDH1A1 (0.34) ALDH1A1KDM4EKMT2ASMN1; SMN2MEN1
SCHEMBL2781979 0.66 ADORA1 (0.37) ALDH1A1KDM4EKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115252799-A Ultrahigh drug-loading compound prepared based on phase transfer inhibition principle and method thereof 中国药科大学 2022-11-01 CN claimed
CN-114146647-A Continuous flow preparation method of high drug-loading microspheres 中国药科大学 2022-03-08 CN claimed
CN-114081867-A Method for improving drug loading capacity of microspheres 中国药科大学 2022-02-25 CN claimed
CN-112603892-A Drug-loaded microsphere and preparation method thereof 中国药科大学 2021-04-06 CN claimed
CN-114096627-B Aqueous coating film-forming composition for forming antifriction coating film and airbag using the same 陶氏东丽株式会社 2023-09-22 CN disclosed
CN-115252799-A Ultrahigh drug-loading compound prepared based on phase transfer inhibition principle and method thereof 中国药科大学 2022-11-01 CN disclosed
EP-3988620-A1 AQUEOUS COATING-FILM-FORMING COMPOSITION FOR FORMING LUBRICATING COATING FILM, AND AIR BAG USING SAID COMPOSITION Dow Toray Co., Ltd. (JP) 2022-04-27 EP disclosed
EP-3988618-A1 OIL-IN-WATER SILICONE EMULSION COMPOSITION AND USE THEREOF Dow Toray Co., Ltd. (JP) 2022-04-27 EP disclosed
CN-111065525-B Original edition for printing and original edition laminate for printing 富士胶片株式会社 2022-03-29 CN disclosed
CN-114146647-A Continuous flow preparation method of high drug-loading microspheres 中国药科大学 2022-03-08 CN disclosed
CN-114096627-A Aqueous coating film-forming composition for forming antifriction coating film, and airbag using same 陶氏东丽株式会社 2022-02-25 CN disclosed
CN-114026155-A Oil-in-water silicone emulsion composition and use thereof 陶氏东丽株式会社 2022-02-08 CN disclosed
CN-101160387-A Improvement of method and the like RECKITT BENCKISER NV (NL) 2008-04-09 CN disclosed
CN-101048469-A Recording ink, ink cartridge, ink record, inkjet recording apparatus, and inkjet recording method RICOH KK (JP) 2007-10-03 CN disclosed
CN-101040014-A Recording ink, and ink cartridge, ink-recorded article, inkjet recording device and inkjet recording method RICOH KK (JP) 2007-09-19 CN disclosed
US-20070191608-A1 Process for preparing 3-aminothienopyridone derivatives CELLTECH R&D LIMITED (GB) 2007-08-16 US disclosed
CN-1958654-A Granule mass SUMITOMO CHEMICAL CO (JP) 2007-05-09 CN disclosed
CN-1903970-A Stain-proofing agent and building board using same NICHIHA CO LTD (JP) 2007-01-31 CN disclosed
US-20060004025-A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors UCB PHARMA S.A. (BE) 2006-01-05 US disclosed
CN-1330116-A Conditioning of organic pigment CLARIANT INT LTD (CH) 2002-01-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191608-A1 Process for preparing 3-aminothienopyridone derivatives MAPK3, MAP3K6, MAP4K1 ALDH1A1 1970/4885KDM4E 1879/4885KMT2A 1464/4885
US-20060004025-A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors MAPK1, CNKSR1, ALK ALDH1A1 1045/4885KDM4E 2174/4885KMT2A 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.